Company: MYGN
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0000899923-25-000028
Chunk: 65

Company: MYRIAD GENETICS INC
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 65
---
 meet the applicable stock ownership requirements within the five-year period to achieve compliance. 2025 Executive Compensation Program for Named Executive Officers The discussion below describes certain compensation actions recently taken by the CHCC with respect to our 2025 compensation program applicable to our NEOs. Consistent with Item 402 of Regulation S-K, our 2025 compensation program will be discussed more fully in our proxy statement for the 2026 Annual Meeting of Stockholders. Base Salary . In December 2024, the CHCC determined to make no changes to the base salaries of our NEOs for 2025. The CHCC plans to reevaluate potential base salary increases for NEOs in mid-2025. 2025 Short-Term Incentive Program . In February 2025, the CHCC adopted the same quantitative performance metrics for the 2025 short-term incentive program as those used in the 2024 short-term incentive program. In addition, the CHCC determined that the relative weighting of the quantitative metrics and MBOs should generally remain the same as those used in the 2024 short-term incentive program. 2025 Long-Term Incentive Program . In March 2025, the CHCC granted long-term incentive awards to each of our NEOs (other than Mr. Riggsbee). The awards granted were RSUs that vest in three equal annual installments beginning on the first anniversary of the grant date. The CHCC plans to grant PSUs to each of our NEOs (other than Mr. Riggsbee) in June 2025 in an amount equal to the same number of RSUs received by each NEO in March 2025. Compensation in Connection with Senior Leadership Transition. On February 24, 2025, Mr. Diaz announced that he will step down as our President and Chief Executive Officer, and resign from our Board, in each case, effective April 30, 2025 (the "Transition Effective Date"). In connection with Mr. Diaz's resignation, we entered into a consulting agreement with Mr. Diaz pursuant to which he has agreed to serve as an advisor to us for one year following the Transition Effective Date. On the same date, the Board appointed (i) Mr. Raha, our current Chief Operating Officer, to succeed Mr. Diaz as our President and Chief Executive Officer and (ii) Mr. Verratti, our current Chief Commercial Officer, to succeed Mr. Raha as our Chief Operating Officer, in each case, effective on the Transition Effective Date. In